The U.S. ACIP will meet on April 15-16 to review AstraZeneca's flu shot, after postponing the February meeting for public input.
PIRC advises AstraZeneca shareholders to oppose several resolutions at the AGM, including political donations, share buybacks, and the pay report.
A panel advising the CDC will meet in April to review vaccines developed by AstraZeneca, as confirmed by a spokesman for the Department of Health and Human Services.
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.